Tag: GILT

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR

OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR


Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE

Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS

CBIS, OLIE, BGMD & Extended Watchlist

Cannabis Science Inc.  CBIS

CBIS is among the medical marijuana cast of characters that we’ve been following for a very long time. We began tracking this play almost two years ago, and have certainly seen a fair bit of dips and rips during that time. Freshest in our minds would be our alerts from this past February, at which point we witnessed huge gains as CBIS rose from the .04-range all way up to .1195.

We decided that now was as good a time as any to re-alert this play, as we’ve noticed it coming off of its 52-week low at .0299. At this time of year, it’s common to see stocks being subjected to tax-loss selling. We want to be on our guard as this period winds down, when selling pressure is likely to be alleviated. Stocks like CBIS stand to gain ground when that happens, as we head into 2014.

Olie, Inc. OLIE

OLIE turned out to be a well-timed call for us from yesterday. The stock may have ended the session in the red, but not before running from .0082 all the way up to a high of .02! That was good for an intraday mega-move of 147% on almost ten times the 3mo. average volume.

As we said, there was a significant pullback into the close at .0097, and with the kind of volatility we’re seeing out of OLIE, we definitely want to pay attention heading into week’s end. Further opportunities could certainly present themselves.

BG Medicine, Inc. BGMD

We had BGMD in yesterday’s extended watchlist, as we were tracking its pullback off of a recent spike. We did in fact get the bounce that we were looking for; following its morning low of .87, the stock would go on to hit a high of 1.05. A strong close at 1.04 suggests that momentum could carry over, and indeed we are seeing the stock gapping up in pre-market trading today.

Extended Watchlist:
ALIM, PERI, PSDV, OXBT, CDTI, TSEM, GILT